Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Urology and Nephrology
Literature
1.
2.
Wakabayashi I, Daimon T (2015) The cardiometabolic index as a new marker determined by adiposity and blood lipids for discrimination of diabetes mellitus. Clinica Chimica Acta Int J Clin Chem 438:274–278CrossRef
3.
Liu X, Wu Q, Yan G et al (2021) Cardiometabolic index: a new tool for screening the metabolically obese normal weight phenotype. J Endocrinol Invest 44(6):1253–1261CrossRefPubMed
4.
Li X, Shi Y, Wei D et al (2023) Impact of a high dietary fiber cereal meal intervention on body weight, adipose distribution, and cardiovascular risk among individuals with type 2 diabetes. Front Endocrinol 14:1283626CrossRef
5.
Mirmiran P, Bahadoran Z, Mirzaei S et al (2014) Dietary intake, changes in lipid parameters and the risk of Hypertriglyceridemia: a prospective approach in the tehran lipid and glucose study. Int J Vitam Nutr Res. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition 84(5–6):269–276CrossRefPubMed
6.
Luo J, Zheng B (2020) Effect of yoga combined with aerobic exercise intervention on morphological and blood lipid indicators in female college students. J Sports Med Phys Fitness 60(3):442–448CrossRefPubMed
7.
Gaesser GA, Rich RG (1984) Effects of high- and low-intensity exercise training on aerobic capacity and blood lipids. Med Sci Sports Exerc 16(3):269–274CrossRefPubMed
Metadata
Title
Higher cardiometabolic index was independently associated with higher chronic kidney disease risk in the general population
Authors
Gang Wang
Zhichun Liu
Publication date
25-03-2024
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 5/2024
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-024-04032-6

Other articles of this Issue 5/2024

International Urology and Nephrology 5/2024 Go to the issue

Urology - Review

The roles of pyroptosis in genitourinary diseases

Nephrology - Letter to the Editor

Neutrophil-to-lymphocyte ratio is an independent risk factor for proteinuria non-remission in idiopathic membranous nephropathy

Urology - Original Paper

Natural history of renal angiomyolipoma in a high-volume center: our experience during more than 15 years of follow up

Nephrology – Letter to the Editor

Response letter

Urology - Original Paper

Ureteral stone volume and female gender predicts perioperative complications after complete ipsilateral upper urinary tract stone removal using flexible ureterorenoscopy

Nephrology - Review

Safety of cinacalcet in children and adolescents with chronic kidney disease-mineral bone disorder: systematic review and proportional meta-analysis of case series
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits